Insider Transactions in Q3 2025 at Veracyte, Inc. (VCYT)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 04
2025
|
Marc Stapley Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
7,667
-2.24%
|
$230,010
$30.41 P/Share
|
|
Sep 02
2025
|
Rebecca Chambers Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,371
-3.88%
|
$161,130
$30.11 P/Share
|
|
Sep 02
2025
|
Marc Stapley Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,914
-2.26%
|
$237,420
$30.11 P/Share
|
|
Sep 02
2025
|
Annie Mc Guire SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,507
-3.6%
|
$105,210
$30.11 P/Share
|
|
Sep 02
2025
|
John Leite Chief Commercial Officer-CLIA |
SELL
Payment of exercise price or tax liability
|
Direct |
2,902
-3.07%
|
$87,060
$30.11 P/Share
|
|
Sep 02
2025
|
Phillip G. Febbo Chief Scientific & Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,955
-2.85%
|
$88,650
$30.11 P/Share
|
|
Sep 02
2025
|
Jonathan Wygant VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,648
-3.4%
|
$49,440
$30.11 P/Share
|